Hyundai Bioscience

048410.KQ

7.80 USD

-0.12

-1.52%

Overview

Last close

7.80 usd

Market cap

374.32M usd

52 week high

23.82 usd

52 week low

6.67 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

35.4482

Price/Book Value

13.6612

Enterprise Value

394.48M usd

EV/Revenue

37.3231

EV/EBITDA

-64.6317

Key financials

Revenue TTM

10.57M usd

Gross Profit TTM

8.28M usd

EBITDA TTM

1.00M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

45.93M usd

Net debt

15.05M usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.